Hypertrophic obstructive cardiomyopathy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study.
|
27737317 |
2016 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Direct gene sequencing of β-myosin heavy chain (MYH7), myosin binding protein-C (MYBPC3), and cardiac troponin T (TNNT2) was performed in 136 unrelated Chinese HC patients.Clinical evaluations were conducted.
|
23711808 |
2013 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
|
24093860 |
2013 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Five hundred fifty-two unrelated hypertrophic cardiomyopathy probands were screened for TNNT2 mutations.
|
22144547 |
2012 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Cardiac Troponin T (TNNT2) mutations are less prevalent in Indian hypertrophic cardiomyopathy patients.
|
22017532 |
2012 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
Biomarker
|
disease |
BEFREE |
The role of large gene deletions and duplications in MYBPC3 and TNNT2 in patients with hypertrophic cardiomyopathy.
|
19666196 |
2010 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We studied the TNNT2 gene in 127 patients with hypertrophic cardiomyopathy and identified three mutations in patients from four families (3.1%): the Phe87Leu mutation, which has not been previously reported, the Arg278Cys mutation (two families) and the Asp271Ile mutation.
|
20038417 |
2009 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
Biomarker
|
disease |
CTD_human |
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype.
|
19087273 |
2008 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
The DeltaGlu160 mutation was observed in a sequence of the TNNT2 gene in a patient with the severe form of hypertrophic cardiomyopathy.
|
16538283 |
2006 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
To further examine the genetic and clinical features of hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T (cTnT) gene, we screened 143 probands from our hypertrophic cardiomyopathy population for mutations in this gene.
|
15246915 |
2004 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We found a five-basepair insertion/deletion polymorphism in intron 3 of TNNT2, one of the genes responsible for hypertrophic cardiomyopathy.
|
14986170 |
2004 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We sequenced exons 8, 9, 13-16, 19, 20, 22-24, and 30 of the MYH7 gene and exons 8, 9, 11, and 14-16 of the TNNT2 gene in 30 HC patients (18-60 years of age) from the region of Asturias (Northern Spain); 25 cases (80%) had a family history of the disease.
|
12881443 |
2003 |
Hypertrophic obstructive cardiomyopathy
|
0.400 |
Biomarker
|
disease |
BEFREE |
Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.
|
8958207 |
1996 |